Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy. (30th April 2018)

• Record Type: Journal Article
• Authors: Patil, Vijay M; Pande, Nikhil; Chandrasekharan, Arun; M, Chandrakanth; Tonse, Raees; Krishnatry, Rahul; Goda, Jayant S; Dsouza, Hollis; Vallathol, Dilip Harindran; Chakraborty, Santam; Gupta, Tejpal; Jalali, Rakesh
• Is Part Of: CNS oncology. Volume 7:Number 2(2018)
• Publication Date: 2018-04-30
• Subjects: clinic based -- clinical -- follow-up -- glioma -- surveillance -- telephonic -- video -- visual; Central nervous system -- Tumors -- Periodicals; 616.99481
• DOI: 10.2217/cns-2017-0024
• Languages: English
• ISSNs: 2045-0907

Abstract

Aim: This study was designed with a primary objective to study the rate of agreement in treatment plan and decisions between video follow-up (VF) and conventional clinic follow-up (CF).Patients & methods: Adult patients with intermediate- to high-grade glioma on adjuvant temozolomide (TMZ) with facilities for live video call were invited to participate in the study.Results: The concurrence in decision of administering TMZ between VF and CF was 100% (p < 0.00). The median cost incurred in VF was US$58.15 while that incurred in CF was US$131.23 (p < 0.00).Conclusion: VF can substitute CF during adjuvant TMZ administration (CTRI/2017/01/007626).